|
US4287341A
(en)
*
|
1979-11-01 |
1981-09-01 |
Pfizer Inc. |
Alkoxy-substituted-6-chloro-quinazoline-2,4-diones
|
|
US6723727B1
(en)
*
|
1996-12-20 |
2004-04-20 |
Hoechst Aktiengesellschaft |
Substituted purine derivatives, processes for their preparation, their use, and compositions comprising them
|
|
EP0903344B1
(en)
*
|
1997-08-21 |
2011-01-26 |
Shiseido Co., Ltd. |
Quinazolin-4-one derivatives, their preparation and their use as hair growth promoters or in external compositions for skin
|
|
US6436919B1
(en)
|
1999-10-01 |
2002-08-20 |
Theravance Inc. |
Local anesthetic compounds
|
|
HRP20020838A2
(en)
*
|
2000-04-25 |
2004-12-31 |
Icos Corp |
Inhibitors of human phosphatidyl-inositol 3-kinase delta
|
|
US6667300B2
(en)
|
2000-04-25 |
2003-12-23 |
Icos Corporation |
Inhibitors of human phosphatidylinositol 3-kinase delta
|
|
AUPR201600A0
(en)
*
|
2000-12-11 |
2001-01-11 |
Fujisawa Pharmaceutical Co., Ltd. |
Quinazolinone derivative
|
|
ATE469648T1
(de)
|
2001-09-05 |
2010-06-15 |
Minerva Biotechnologies Corp |
Zusammensetzungen und deren verwendung zur behandlung von krebs
|
|
EP1434584A2
(en)
*
|
2001-09-05 |
2004-07-07 |
Minerva Biotechnologies Corporation |
Compositions and methods of treatment of cancer
|
|
WO2003039460A2
(en)
*
|
2001-11-07 |
2003-05-15 |
Merck & Co., Inc. |
Mitotic kinesin inhibitors
|
|
AUPS019702A0
(en)
*
|
2002-01-29 |
2002-02-21 |
Fujisawa Pharmaceutical Co., Ltd. |
Condensed heterocyclic compounds
|
|
US20040048853A1
(en)
*
|
2002-08-21 |
2004-03-11 |
Gustave Bergnes |
Compounds, compositions, and methods
|
|
CA2502302A1
(en)
*
|
2002-11-04 |
2004-05-21 |
Nps Pharmaceuticals, Inc. |
Quinazolinone compounds as calcilytics
|
|
ATE440825T1
(de)
*
|
2003-06-06 |
2009-09-15 |
Vertex Pharma |
Pyrimidin-derivate zur verwendung als modulatoren von atp-bindende kassette transportern
|
|
US20050054614A1
(en)
*
|
2003-08-14 |
2005-03-10 |
Diacovo Thomas G. |
Methods of inhibiting leukocyte accumulation
|
|
WO2005016348A1
(en)
*
|
2003-08-14 |
2005-02-24 |
Icos Corporation |
Method of inhibiting immune responses stimulated by an endogenous factor
|
|
RS55551B1
(sr)
|
2004-05-13 |
2017-05-31 |
Icos Corp |
Hinazolinoni kao inhibitori humane fosfatidilinozitol 3-kinaze delta
|
|
EP1755609A1
(en)
*
|
2004-05-25 |
2007-02-28 |
Icos Corporation |
Methods for treating and/or preventing aberrant proliferation of hematopoietic cells
|
|
CA2598409A1
(en)
*
|
2005-02-17 |
2006-08-24 |
Icos Corporation |
Phosphoinositide 3-kinase inhibitors for inhibiting leukocyte accumulation
|
|
EP2233472B1
(en)
*
|
2006-03-28 |
2014-01-15 |
Atir Holding S.A. |
Heterocyclic compounds and uses thereof in the treatment of sexual disorders
|
|
US9492449B2
(en)
|
2008-11-13 |
2016-11-15 |
Gilead Calistoga Llc |
Therapies for hematologic malignancies
|
|
KR101664511B1
(ko)
|
2008-11-13 |
2016-10-11 |
길리아드 칼리스토가 엘엘씨 |
혈액 종양에 대한 요법
|
|
BRPI1012333A2
(pt)
|
2009-03-24 |
2016-03-29 |
Gilead Calistoga Llc |
atropisômeros de derivados de 2-purinil-3-tolil-quinazolinonas e métodos de uso
|
|
JP2012524126A
(ja)
*
|
2009-04-20 |
2012-10-11 |
ギリアド カリストガ リミテッド ライアビリティ カンパニー |
固形腫瘍の治療方法
|
|
CN102647987A
(zh)
|
2009-07-21 |
2012-08-22 |
吉里德卡利斯托加公司 |
使用pi3k抑制剂治疗肝脏障碍
|
|
BRPI1003506B1
(pt)
|
2010-09-24 |
2019-12-03 |
Ache Int Bvi Ltd |
composto alquil-piperazino-fenil-4(3h)quinazolinonas e uso do composto alquil-piperazino-fenil-4(3h)quinazolinonas associado aos receptores serotoninérgicos 5-ht1a e 5-ht2a
|
|
EP3581567A1
(en)
*
|
2011-04-10 |
2019-12-18 |
Atir Holding S.A. |
Heterocyclic compounds and uses thereof in the treatment of sexual disorders
|
|
PT2834241T
(pt)
|
2012-03-05 |
2021-02-05 |
Gilead Calistoga Llc |
Formas polimórficas de (s)-2-(1-(9h-purin-6-ilamino)propil)-5-fluoro-3-fenil quinazolina-4(3h)-ona
|
|
IN2015MN00002A
(OSRAM)
|
2012-07-09 |
2015-10-16 |
Lupin Ltd |
|
|
US9708327B2
(en)
|
2013-12-20 |
2017-07-18 |
Gilead Calistoga Llc |
Polymorphic forms of a hydrochloride salt of (S)-2-(1-(9H-purin-6-ylamino)propyl)-5-fluoro-3-phenylquinazolin-4(3H)-one
|
|
US9567337B2
(en)
|
2013-12-20 |
2017-02-14 |
Gilead Calistoga Llc |
Process methods for phosphatidylinositol 3-kinase inhibitors
|
|
HK1231476A1
(zh)
|
2014-06-13 |
2017-12-22 |
吉利德科学公司 |
磷脂酰肌醇3-激酶抑制剂
|